Stelara is biologic therapy that is indicated for treating
- moderately to severely active Crohn’s disease (CD) where treatment with immunomodulators, corticosteroids, or one or more TNF blockers failed
- active psoriatic arthritis
- moderate to severe plaque psoriasis with a candidacy for phototherapy or systemic therapy
Stelara is a medicine that targets the immune proteins IL-12 and IL-23.
IL-12 and IL-23 are believed to be associated with inflammation in plaque psoriasis, the gastrointestinal lining, joints and skin structures.
For patients with Crohn’s disease, Stelara is administered once every eight weeks until patients have received six total treatments.
For patients with psoriatic arthritis or plaque psoriasis, Stelara is administered at week one and week 4, followed by doses received every 12 weeks.
How Stelara works in Crohn's Disease
Patients choose Red Bank Infusion Center
to have their Stelara therapy because
- of our flexible, worry-free scheduling, with evening and weekend appointments available
- our all-private infusion suites, with the latest COVID safety standards in place for your protection
- equipped with medical-grade, leather recliners, with chairs and amenities for your guests
- including large, flat screen TVs, free WiFi and entertainment channels for your viewing pleasure
- and our friendly, helpful clinical staff providing personalized service
Want to move to
Red Bank Infusion Center?
We make it simple and convenient for you to start your infusion care with us.
